Clinical trial
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
NCT01497938 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
- Lead sponsor
- Medtronic MiniMed, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- June 30, 2013
- Enrollment
- 247 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes